相似文献
1
Association between Type 2 Diabetes Mellitus and Brain Atrophy: A Meta-Analysis (Diabetes Metab J 2022;46:781-802).
Diabetes Metab J. 2022 Sep;46(5):813-814. doi: 10.4093/dmj.2022.0259. Epub 2022 Sep 19.
2
Association between Type 2 Diabetes Mellitus and Brain Atrophy: A Meta-Analysis (Diabetes Metab J 2022;46:781-802).
Diabetes Metab J. 2022 Sep;46(5):815-816. doi: 10.4093/dmj.2022.0296. Epub 2022 Sep 19.
3
Safety of COVID-19 Vaccines among Patients with Type 2 Diabetes Mellitus: Real-World Data Analysis (Diabetes Metab J 2023;47:356-65).
Diabetes Metab J. 2023 Sep;47(5):715-716. doi: 10.4093/dmj.2023.0269. Epub 2023 Sep 26.
4
Safety of COVID-19 Vaccines among Patients with Type 2 Diabetes Mellitus: Real-World Data Analysis (Diabetes Metab J 2023;47:356-65).
Diabetes Metab J. 2023 Sep;47(5):717-718. doi: 10.4093/dmj.2023.0300. Epub 2023 Sep 26.
5
SGLT2 inhibitors increase risk for diabetic ketoacidosis in type 2 diabetes.
Ann Intern Med. 2020 Oct 20;173(8):JC40. doi: 10.7326/ACPJ202010200-040.
6
Association of Body Mass Index and Fracture Risk Varied by Affected Bones in Patients with Diabetes: A Nationwide Cohort Study (Diabetes Metab J 2023;47:242-54).
Diabetes Metab J. 2023 May;47(3):439-440. doi: 10.4093/dmj.2023.0104. Epub 2023 May 26.
7
Association of Body Mass Index and Fracture Risk Varied by Affected Bones in Patients with Diabetes: A Nationwide Cohort Study (Diabetes Metab J 2023;47:242-54).
Diabetes Metab J. 2023 May;47(3):437-438. doi: 10.4093/dmj.2023.0100. Epub 2023 May 26.
8
Association between Type 2 Diabetes Mellitus and Brain Atrophy: A Meta-Analysis.
Diabetes Metab J. 2022 Sep;46(5):781-802. doi: 10.4093/dmj.2021.0189. Epub 2022 Mar 8.
9
Letter: Efficacy and Safety of Voglibose Plus Metformin in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial ( 2019;43;276-86).
Diabetes Metab J. 2019 Aug;43(4):545-546. doi: 10.4093/dmj.2019.0130.
10
Response: Efficacy and Safety of Voglibose Plus Metformin in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial ( 2019;43;276-86).
Diabetes Metab J. 2019 Aug;43(4):547-548. doi: 10.4093/dmj.2019.0148.
本文引用的文献
1
Association between Type 2 Diabetes Mellitus and Brain Atrophy: A Meta-Analysis.
Diabetes Metab J. 2022 Sep;46(5):781-802. doi: 10.4093/dmj.2021.0189. Epub 2022 Mar 8.
2
Hippocampal subfields atrophy contribute more to cognitive impairment in middle-aged patients with type 2 diabetes rather than microvascular lesions.
Acta Diabetol. 2021 Aug;58(8):1023-1033. doi: 10.1007/s00592-020-01670-x. Epub 2021 Mar 22.
3
Impact of Intensive Glucose Control on Brain Health: Meta-Analysis of Cumulative Data from 16,584 Patients with Type 2 Diabetes Mellitus.
Diabetes Ther. 2021 Mar;12(3):765-779. doi: 10.1007/s13300-021-01009-x. Epub 2021 Feb 6.
4
Long-term Change in Physiological Markers and Cognitive Performance in Type 2 Diabetes: The Look AHEAD Study.
J Clin Endocrinol Metab. 2020 Dec 1;105(12):e4778-91. doi: 10.1210/clinem/dgaa591.
5
Impact of antidiabetic agents on dementia risk: A Bayesian network meta-analysis.
Metabolism. 2020 Aug;109:154265. doi: 10.1016/j.metabol.2020.154265. Epub 2020 May 22.
6
Importance of Treatment Status in Links Between Type 2 Diabetes and Alzheimer's Disease.
Diabetes Care. 2019 May;42(5):972-979. doi: 10.2337/dc18-1399. Epub 2019 Mar 4.
7
Does Intensive Glucose Control Prevent Cognitive Decline in Diabetes? A Meta-Analysis.
Int J Chronic Dis. 2015;2015:680104. doi: 10.1155/2015/680104. Epub 2015 Aug 4.
8
Brain atrophy in type 2 diabetes: regional distribution and influence on cognition.
Diabetes Care. 2013 Dec;36(12):4036-42. doi: 10.2337/dc13-0143. Epub 2013 Aug 12.
9
Risk of dementia in diabetes mellitus: a systematic review.
Lancet Neurol. 2006 Jan;5(1):64-74. doi: 10.1016/S1474-4422(05)70284-2.
10
Correlation between rates of brain atrophy and cognitive decline in AD.
Neurology. 1999 May 12;52(8):1687-9. doi: 10.1212/wnl.52.8.1687.
Zotero 插件